Gharibwal Cement Limited (PSX:GWLC)

Oncternal Therapeutics Revenue

Gharibwal Cement had revenue of 4.92B PKR in the quarter ending March 31, 2025, with 16.18% growth. This brings the company's revenue in the last twelve months to 19.48B, up 9.88% year-over-year. In the fiscal year ending June 30, 2024, Gharibwal Cement had annual revenue of 18.17B, down -0.82%.

• Revenue (ttm): 19.48B
• Revenue Growth: +9.88%
• P/S Ratio: 0.98
• Revenue / Employee: 51.12M
• Employees: 381
• Market Cap: 19.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	18.17B	-150.81M	-0.82%
Jun 30, 2023	18.32B	2.12B	13.10%
Jun 30, 2022	16.19B	4.09B	33.76%
Jun 30, 2021	12.11B	3.39B	38.94%
Jun 30, 2020	8.71B	-2.46B	-22.02%